Van Bael & Bellis houses a broad practice which advises a lucrative client base, which notably includes Amgen, Eli Lily, and Gilead. The group is proficient in handling product liability issues, parallel import disputes, and distribution strategies. Catherine Longeval co-heads the team alongside Peter L’Ecluse. Dispute resolution specialist Longeval has a great deal of knowledge spanning medicines, cosmetics, and biotech products, while L'Ecluse is noted for handling a broad range of issues, including pricing and reimbursement mandates, and advertising matters, regularly appearing before the Council of State to challenge reimbursement decisions. Michael Clancy is known for his competition law expertise, particularly in relation to promotional activities, R&D collaborations, and pricing strategies.
Key clients
- AbbVie
- Amgen
Work highlights
- Advising Novo Nordisk on a range of regulatory matters, including sponsorship projects, advertising of medicines, and the use of clinical trial data.